BioMedical SIG #8

BioMedical SIG #8

Join us for the final webinar in the BioMedical SIG series: The Regulatory Path from Academic Drug Discovery to Market Authorisation Application.

Book Your Place

This event has now expired

Many drugs start life in academia. However, limited understanding of the drug development path and more specifically of regulatory aspects that should be considered hinder progress. This session will provide an overview of the regulatory path for medicines and how it aligns and feeds into the design of pre-clinical, non-clinical, clinical and quality (chemistry, manufacturing, control – CMC) studies that are necessary for preparing a clinical trial submission and ultimately a marketing authorization application. Critical concept will be discussed that academic researchers or early-stage entrepreneurs must be aware and which can help support progressing their drug development work, accessing funding and building partnerships.

This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.

Booking Options

  • Are you an ASTP Member?

  • By proceeding with this booking, you are agreeing to allow ASTP to use your image solely for promotional and educational purposes.

Testimonials

testimonial

Thank you for such enjoyable inspiring event, great choice of the lecturers!!!

Linda Ondrackova

University of Pardubice, Czech Republic

testimonial

Was great to meet counterparts in my profession who may share my experiences, but who may also have other ideas and approaches.

Tim Moser

Netherlands Cancer Institute, Netherlands

testimonial

Always simply inspiring! That is ASTP.

Filip Auinger

Palacký University Olomouc, Czech Republic

testimonial

The software training filled in the many blanks and brought my 'fractioned' knowledge in a structured way. Very useful!

Ilse Sienaert

KU Leuven R&D, Belgium

testimonial

ASTP brought the right structure and terminology to my knowledge of technology licensing.

René Widmer

ETH Transfer, Switzerland